News

Healio28d
FDA approves first therapy to treat hyperphagia in Prader-Willi syndrome
Prader-Willi syndrome is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15, according to a press release from Soleno Therapeutics.
Investing28d
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
The drug, to be called Vykat XR, treats hyperphagia, the hallmark symptom of the Prader-Willi syndrome, a genetic disorder caused by full or partial deletions on chromosome 15 that affect the ...
Stocktwits on MSN10d
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved
Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...
PMLiVE28d
FDA approves Soleno’s Vykat XR as first treatment for hyperphagia in Prader-Willi syndrome
The US Food and Drug Administration (FDA) has approved Soleno Therapeutics’ Vykat XR (diazoxide choline) extended-release tablets as the first treatment to address hyperphagia in patients with the ...
pharmaphorum28d
FDA clears first treatment for Prader-Willi syndrome
Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS ... to groups of genes found on chromosome 15. The once-daily, oral drug can be used ...
Yahoo News Canada29d
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
The drug, to be called Vykat XR, treats hyperphagia, the hallmark symptom of the Prader-Willi syndrome, a genetic disorder caused by full or partial deletions on chromosome 15 that affect the ...
Managed Healthcare Executive28d
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
Prader-Willi is caused by an abnormality in the gene expression on chromosome 15. A key characteristic is a sensation ... Diabetes is common among patients with Prader-Willi syndrome, but researchers ...